72
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with Type 2 diabetes mellitus

, &
Pages 483-489 | Published online: 08 Jul 2009

REFERENCES

  • American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 1998; 21 Suppl. 1: S23–31.
  • Krolewski AS, Warram JH. Natural history of diabetic nephropathy. Diabetes Rev 1995; 3: 446 — 59.
  • Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263–85.
  • Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M, Lundwall A, Jensson 0, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287–94.
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933— 53.
  • Jung K, Schulze BD, Sydow K, Pergande M, Precht K, Schreiber G. Diagnostic value of low-molecular mass proteins in serum for detection of reduced glomerular filtration rate. J Clin Chem Biochem 1987; 25: 499–503.
  • Van Lente F, Suit P. Assessment of renal function by serum creatinine and creatinine clearance: glomerular filtration rate estimated by four procedures. Clin Chem 1989; 35: 2326–30.
  • Galli G, Rufini V, Vellante C, D'errico G, Piraccini R. Estimation of glomerular filtration rate with 99Tcm-DTPA: a comparative assessment of simplified methods. Nucl Med Commun 1997; 18: 634–41.
  • Swan SK. The search continues—an ideal marker of GFR. Clin Chem 1997; 43: 913–4.
  • Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 1994; 46: S17–19.
  • Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921— 6.
  • Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312–8.
  • Mojiminiyi OA, Al Shayji I, George S. Serum cystatin C could replace serum creatinine as an indicator of glomerular filtration rate in routine practice. Eur J Lab Med 1998; 6: 98–101.
  • O'Connor DT, Pandian MR, Carlton E, Cervenka JH, Hsiao RJ. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem 1989; 35: 1631–7.
  • Boomsma F, Bhaggoe UM, Man in et Veld AJ, Schalekamp ADH. Sensitivity and specificity of a new ELISA method for determination of chromo-granin A in the diagnosis of phaeochromocytoma and neuroblastoma. Clin Chim Acta 1995; 239: 57–63.
  • Mojiminiyi OA, George S. Serum chromogranin A and its relationship to endogenous markers of glomerular filtration rate. Ann Clin Biochem 1999; 36: 247–9.
  • Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.
  • Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving H-H, Steffes MW, Striker GE. Screening and management of microalbumi-nuria in patients with diabetes mellitus. Am J Kidney Dis 1995; 25: 107–12.
  • Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE. Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 1995; 47: 1781–9.
  • Liew BS, Perry C, Boulton-Jones JM, Simpson K, Paterson K. Diabetic nephropathy: an observa-tional study on patients attending a joint diabetes renal clinic. QJM 1997; 90: 353–8.
  • DeFronzo RA. Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 1995; 3: 510–64.
  • Rudberg S, Osterby R. Decreasing glomerular filtration rate—an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? Nephrol Dial Transplant 1997; 12: 1149–54.
  • Soper CP, Barron JL, Hyer SL. Long-term glycaemic control directly correlates with glomer-ular filtration rate in early Type 1 diabetes mellitus before the onset of microalbuminuria. Diabetes Med 1998; 15: 1010–4.
  • Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993; 16: 773–9.
  • Sterner NG, Nilsson H, Rosen U, Lilja B, Sundkvist G. Relationships among glomerular filtration rate, albuminuria, and autonomic nerve function in insulin-dependent and non-insulin-dependent diabetes mellitus. J Diabetes Complica-tions 1997; 11: 188–93.
  • Hong CY, Chia KS. Markers of diabetic nephro-pathy. J Diabetes Complications 1998; 12: 43–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.